Amneal Pharmaceuticals (AMRX) PT Raised to $11 at Piper Sandler

November 11, 2024 7:22 AM EST Send to a Friend
Piper Sandler analyst David Amsellem raised the price target on Amneal Pharmaceuticals (NASDAQ: AMRX) to $11.00 (from $9.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login